Greene Barry E Insider Trades

Insider Trading History

Track insider trading activity for Greene Barry E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $148k 16,415 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 15,508 shares
$8.06
$9.00
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$407k 46,940 shares
$8.68
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.97M 227,229 shares
$8.68
$8.68
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $41.4k 4,600 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.6k 4,600 shares
$4.48
$9.00
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $1.51M 174,000 shares
Last Trade
Jan 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.21M 174,000 shares
$6.97
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $845k 97,340 shares
Last Trade
Aug 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$452k 50,400 shares
$8.96
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $738k 85,067 shares
Last Trade
Aug 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$110k 12,273 shares
$8.96
$8.68
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $621k 69,000 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$996k 69,000 shares
$14.43
$9.00
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $1.46M 168,000 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.87M 168,000 shares
$23.02
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $1.69M 195,000 shares
Last Trade
Aug 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.04M 195,000 shares
$36.10
$8.68
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $306k 34,000 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 34,000 shares
$37.50
$9.00
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $577k 66,500 shares
Last Trade
Feb 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.01M 66,500 shares
$45.28
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director, President And CEO
Holding Value $407k 46,940 shares
Last Trade
Nov 10, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$500k 14,500 shares
$34.48
$8.68
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$564k 7,576 shares
$74.40
$9.00
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $215k 23,900 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.03M 23,900 shares
$84.75
$9.00
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $607k 69,920 shares
Last Trade
Feb 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.01M 69,920 shares
$43.04
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $282k 32,440 shares
Last Trade
Aug 05, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.02M 23,640 shares
$43.15
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
President And CEO
Holding Value $76.4k 8,800 shares
Last Trade
Jun 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$496k 8,800 shares
$56.32
$8.68
Acorda Therapeutics
Acorda Therapeutics ACOR
Director
Holding Value $6.61k 10,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 10,000 shares
$3.75
$0.66
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $215k 23,900 shares
Last Trade
May 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.38M 23,900 shares
$141.30
$9.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up